Factbox: Labor, environment, drugs top changes to North American trade deal

Factbox: Labor, environment, drugs top changes to North American trade deal
MEXICO CITY (Reuters) – Stronger worker and environmental protections top changes to a new version of the North American trade deal signed by U.S., Mexican and Canadian officials on Tuesday that clears the way for a long-delayed vote in the U.S. Congress. FILE PHOTO: Canadian Deputy Prime Minister Chrystia Freeland gestures as she speaks during a meeting at the Presidential... Read More

France’s Sanofi to buy biotech firm Synthorx for $2.5 billion

France’s Sanofi to buy biotech firm Synthorx for $2.5 billion
PARIS (Reuters) – Sanofi (SASY.PA) said on Monday it had agreed to buy California-headquartered biotechnology firm Synthorx in a cash deal worth about $2.5 billion aimed at beefing up the French drugmaker’s pipeline of drugs for cancer and auto-immune disorders. FILE PHOTO: The logo of Sanofi is seen at the company’s research and production centre in Vitry-sur-Seine, France, August 6,... Read More

Pfizer, Novartis lead $2 billion spending spree on gene therapy production

Pfizer, Novartis lead $2 billion spending spree on gene therapy production
(Reuters) – Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018, according to a Reuters analysis, in a drive to better control production of the world’s priciest medicines. FILE PHOTO: A logo for Pfizer is displayed on a monitor on the floor at the New York Stock... Read More

Pfizer, Novartis lead pharma spending spree on gene therapy production

Pfizer, Novartis lead pharma spending spree on gene therapy production
(Reuters) – Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018, according to a Reuters analysis, in a drive to better control production of the world’s priciest medicines. FILE PHOTO: A logo for Pfizer is displayed on a monitor on the floor at the New York Stock... Read More

H&M-backed startup puts bacteria to work in green dyeing process

H&M-backed startup puts bacteria to work in green dyeing process
STOCKHOLM/NORWICH, Britain (Reuters) – A British biotech startup is developing a method of textile dyeing that taps into the bright colors of birds and butterflies and has micro-organisms recreate them on fabric, slashing the use of water and heavy chemicals in the process. Patchwork of different types of material dyed using bacteria in a lab at biotech firm Colorifix in... Read More

Novartis takes on Sanofi, Amgen with $9.7 billion takeover of heart drug maker

Novartis takes on Sanofi, Amgen with $9.7 billion takeover of heart drug maker
ZURICH (Reuters) – Swiss drugmaker Novartis (NOVN.S) is betting on heart drug prospect inclisiran in a $9.7 billion takeover of The Medicines Co (MDCO.O) as it challenges cardiovascular medicines from Amgen Inc (AMGN.O), Sanofi (SASY.PA) and Regeneron Pharmaceuticals (REGN.O). FILE PHOTO: Switzerland’s national flag flies in front of the logo of Swiss drugmaker Novartis in Basel, Switzerland, January 30, 2019.... Read More

Novartis to buy U.S. biotech The Medicines Co. for $9.7 billion

Novartis to buy U.S. biotech The Medicines Co. for $9.7 billion
ZURICH (Reuters) – Novartis AG (NOVN.S) is buying U.S. biotechnology company The Medicines Co (MDCO.O) for about $9.7 billion, the Swiss drugmaker said on Sunday, as it seeks to expand its portfolio of medicines against cardiovascular disease. FILE PHOTO: Switzerland’s national flag flies in front of the logo of Swiss drugmaker Novartis in Basel, Switzerland, January 30, 2019. REUTERS/Arnd Wiegmann/File... Read More

Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ

Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ
FILE PHOTO: Switzerland’s national flag flies in front of the logo of Swiss drugmaker Novartis in Basel, Switzerland, January 30, 2019. REUTERS/Arnd Wiegmann/File Photo (Reuters) – Swiss drugmaker Novartis AG (NOVN.S) is nearing an agreement to acquire U.S. biotechnology firm The Medicines Co (MDCO.O) for about $7 billion, the Wall Street Journal reported on Saturday. The deal, in which Novartis... Read More

U.S. healthcare shares pick up steam as some political worries abate

U.S. healthcare shares pick up steam as some political worries abate
NEW YORK (Reuters) – U.S. healthcare stocks, led by health insurers, have gained strength in recent weeks, buoyed by solid third-quarter earnings and investor comfort that political risks to the sector have eased. Wednesday’s Democratic presidential debate could test their momentum. FILE PHOTO: The set and ten podiums for the next U.S. Democratic presidential candidates’ debate are seen the day... Read More

Former drug executive Shkreli’s appeal denied by U.S. Supreme Court

Former drug executive Shkreli’s appeal denied by U.S. Supreme Court
FILE PHOTO: Former drug company executive Martin Shkreli arrives at U.S. District Court for the fifth day of jury deliberations in his securities fraud trial in the Brooklyn borough of New York City, U.S., August 4, 2017. REUTERS/Carlo Allegri (Reuters) – Former pharmaceutical executive Martin Shkreli will remain in prison after the U.S. Supreme Court on Monday rejected his effort... Read More